Can't wait till March? Join us in October in Boston. Find out more
#rnaleaders @lsxleaders
Created by
A new paradigm for disease prevention
RNA medicines are at a critical moment in time. mRNA vaccines dominate the headlines in the wake of the COVID-19 pandemic. But huge advances are also being made in RNAi and antisense technologies. Our understanding of RNA chemistry continues to mature. Delivery tools are increasingly sophisticated and impactful. Advances in genomics and gene editing are driving new approaches. And exciting work targeting RNA with small molecules is emerging.
With that in mind, we can’t wait to bring the community together, face-to-face, for the second annual RNA Leaders Europe Congress.
So, if you’re passionate about all things RNA do join us, and more than 600 biotech, pharmaceutical, investment, regulatory and scientific professionals at the RNA Leaders Europe Congress. You’ll hear the latest advances in RNA chemistry, get clinical updates from the companies developing new therapies and source the services partners who are helping to deliver drugs to patients.
Meet the 2022 speakers
Douglas Fambrough
CEO
Dicerna Pharmaceuticals
Melissa Moore
CSO
Moderna
Angele Maki
SVP, Business Development
ReCode Therapeutics
Sylke Poehling
Senior Vice President and Global Head
Therapeutic ModalitiesRoche
Shalini Andersson
Chief Scientist, New Therapeutic Modalities & Head of Oligonucleotide Discovery
AstraZeneca
Denis Drygin
CSO
Regulus Therapeutics
Huw Nash,
COO and CBO
Stoke Therapeutics
Matthew Wood
Professor of Neuroscience and Deputy Head, Medical Sciences Division
University of Oxford
Laura Sepp-Lorenzino
CSO
Intellia Therapeutics
Howard Stern
CSO
Korro Bio
David Slack
CEO
Cend Therapeutics
Sudha Chivukula
Head of RNA Technology, Research & External Innovation
Sanofi Pasteur
Tamar Grossman
Global Head of RNA and Targeted Therapeutics
Janssen
Peter Smith
Co-Founder, President and CEO
Remix Therapeutics
Bill Haney
CEO & Chairman
Skyhawk Therapeutics
Malgorzata Gonciarz
Associate Vice President, Genetic Medicine
Eli Lilly
What Our Attendees Say
"One of the best conferences I have attended."
Dietrich A. Stephan, Ph.D Chairman, Founder and CEO, Neubase Therapeutics
"It has been really well executed with insightful talks, top-class attendance and remarkable organization."
Solène Guilliot Director of Clinical Development and Medical Affairs, Medesis Pharma
"Highly relevant talks and panel discussions, and an interesting participant mix of big pharma, biotech, manufacturers and bio investors."
Marie Wikstrom Lindholm SVP, Head of Molecular Design, Silence Therapeutics
"A fantastic environment in which to discuss the state of the RNA world with the best professionals in its different variants and technologies and to make new professional relationships."
Tamara Martinez R+D Manager, Sylentis
"Very high quality meeting and extremely valuable networking event with leaders present from across all RNA domains and from Europe and the US. Extremely worthwhile."
Matthew Wood Professor of Neuroscience, University of Oxford
Platinum partners
Gold partners
Silver partners
Bronze partners
What will you learn?
How the RNA field has accelerated in the past two years, including major scientific and clinical developments
New advancements in systemic and topical delivery platforms and their applications
How computational biology is advancing RNA drug discovery including new tools for target, mechanism and molecule discovery
Latest pre-clinical updates spanning mRNA, RNAi, antisense and targeting RNA with small molecules
Application of gene therapy and RNA editing approaches
4000+ live clinical trials for RNA therapeutics and vaccines
2 major mRNA vaccine approvals in 2020
3 RNAi therapeutic approvals in the past 4 years
1500+ investors actively looking to fund RNA technology
96 successful fund raises by mid 2021 (vs 101 total in 2020)
More than $1.65bn raised by RNA biotech mid 2021
Millions of lives saved by mRNA vaccines to date
Become a partner
Do you offer products or services to support RNA drug development? The pharma and biotech executives attending RNA Leaders World Congress want to meet you! They are looking for:
